Skip to main content
. Author manuscript; available in PMC: 2023 Jul 27.
Published in final edited form as: Pathology. 2022 Dec 29;55(2):206–213. doi: 10.1016/j.pathol.2022.12.345

Table 2.

Criteria for melanocytic neoplasms of low malignant potential (MNLMP)

Age (≤69 in model 1A, ≤43 in model 1B)
Breslow thickness <0.4 mm (Eguchi et al., in press)
Mitotic rate Zero
Clark level Ior II
Vertical growth phase (VGP) Absent
Ulceration Absent
Radial growth phase regression Absent44,58
Dynamic clinical changes Absent